Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis

Vincenzo La Milia1, Monica Limardo, Andrea Cavalli

  • 1Department of Nephrology and Dialysis, A. Manzoni Hospital, Lecco, Italy. v.lamilia@ospedale.lecco.it

Insights

Peritoneal dialysis (PD) patients with high membrane transport face increased risks. Assessing membrane transport before and after PD initiation, especially comparing continuous ambulatory PD (CAPD) and automated PD (APD), offers valuable insights.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Membrane Physiology

Background:

  • High small solute peritoneal membrane transport in peritoneal dialysis (PD) patients is linked to increased morbidity and mortality.
  • The peritoneal equilibration test (PET) assesses membrane transport, typically performed after the first month of PD due to early transport changes.
  • Early assessment of membrane transport before and after PD initiation is crucial.

Purpose of the Study:

  • To evaluate small solute peritoneal membrane transport characteristics before and after initiating PD.
  • To compare membrane transport changes between continuous ambulatory PD (CAPD) and automated PD (APD) modalities.

Main Methods:

  • Small solute peritoneal membrane transport was assessed in 34 patients prior to starting PD.
  • Twenty-two patients were treated with CAPD and 12 with APD.
  • Peritoneal equilibration tests (PET) were conducted before and at intervals after PD initiation.

Main Results:

  • Small solute peritoneal membrane transport increased in CAPD patients four months after PD initiation (D/P(Creat) from 0.66 ± 0.12 to 0.73 ± 0.07).
  • In contrast, APD patients showed no significant increase in transport (D/P(Creat) from 0.64 ± 0.12 to 0.61 ± 0.07).
  • After approximately 16 months, CAPD patients exhibited higher peritoneal membrane transport (D/P(Creat) = 0.74 ± 0.06) compared to APD patients (D/P(Creat) = 0.63 ± 0.10).

Conclusions:

  • Performing PET before and after PD initiation provides critical information on small solute peritoneal membrane transport.
  • This assessment aids in understanding the influence of PD modality (CAPD vs. APD) on peritoneal membrane transport dynamics.
  • Early and serial PET evaluations can help personalize PD therapy based on individual membrane transport characteristics.
Abstract

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...